Quick answer
Regeneron Pharmaceuticals, Inc. (REGN) reported diluted EPS of $12.23 for the quarter ended 2026-06-30, in a 10-Q filed with the SEC on 2026-07-30. Its last four 10-Q/10-K filings were on 2026-07-30, 2026-04-29, 2026-02-04, 2025-10-28.
Data as of 2026-07-30. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Period end | Period | Form | SEC filing date | Diluted EPS |
|---|---|---|---|---|
| 2026-06-30 | Quarter | 10-Q | 2026-07-30 | $12.23 |
| 2026-03-31 | Quarter | 10-Q | 2026-04-29 | $6.75 |
| 2025-12-31 | Full year | 10-K | 2026-02-04 | $41.48 |
| 2025-09-30 | Quarter | 10-Q | 2025-10-28 | $13.62 |
| 2025-06-30 | Quarter | 10-Q | 2025-08-01 | $12.81 |
| 2025-03-31 | Quarter | 10-Q | 2025-04-29 | $7.27 |
| 2024-12-31 | Full year | 10-K | 2025-02-05 | $38.34 |
| 2024-09-30 | Quarter | 10-Q | 2024-10-31 | $11.54 |
| 2024-06-30 | Quarter | 10-Q | 2024-08-01 | $12.41 |
| 2024-03-31 | Quarter | 10-Q | 2024-05-02 | $6.27 |
| 2023-12-31 | Full year | 10-K | 2024-02-05 | $34.77 |
| 2023-09-30 | Quarter | 10-Q | 2023-11-02 | $8.89 |
| 2023-06-30 | Quarter | 10-Q | 2023-08-03 | $8.50 |
| 2023-03-31 | Quarter | 10-Q | 2023-05-04 | $7.17 |
| 2022-12-31 | Full year | 10-K | 2023-02-06 | $38.22 |
| 2022-09-30 | Quarter | 10-Q | 2022-11-03 | $11.66 |
Related
- RBRK earnings report dates and EPS history (Rubrik, Inc.)
- RCL earnings report dates and EPS history (Royal Caribbean Cruises Ltd)
- RDDT earnings report dates and EPS history (Reddit, Inc.)
- REXR earnings report dates and EPS history (Rexford Industrial Realty, Inc.)
- RF earnings report dates and EPS history (Regions Financial Corporation)
- RGA earnings report dates and EPS history (Reinsurance Group Of America, Incorporated)
- RGEN earnings report dates and EPS history (Repligen Corp)
- RGLD earnings report dates and EPS history (Royal Gold, Inc)
Last updated 2026-10-16. Data only, not financial or tax advice.